newsfilter
← Latest News
Business Wire·

DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes

DiaMedica Therapeutics Inc. (NASDAQ:DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia and acute ischemic stroke, today announced its upcoming addition as a member